Original Research

Published on 10 Oct 2024

Design and validation of a questionnaire to measure the attitudes of health professionals towards immigrants (AHPI)

in Drugs Outcomes Research and Policies

Iwona Niewiadomska
Krzysztof Jurek
Beata Dobrowolska
Alina Deluga
Izabela Mamcarz

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1287536

495 views

Policy and Practice Reviews

Published on 09 Oct 2024

Pathways for non-manufacturers to drive generic drug repurposing for cancer in the U.S.

in Drugs Outcomes Research and Policies

Devon Crittenden
Raquel Gallagher
Fernanda Milans del Bosch
David M. Fox
Laura B. Kleiman

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419772

1,121 views

Systematic Review

Published on 08 Oct 2024

Management of blood lipids in post-kidney transplant patients: a systematic review and network meta-analysis

in Drugs Outcomes Research and Policies

Bohan Luo
Shan Zhong
Xiaoxiao Wang
Pu Guo
Yifu Hou
Wenjia Di

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440875

636 views

Original Research

Published on 04 Oct 2024

Identifying and presenting key country-specific indicators related to medication adherence: a comprehensive study across European countries

in Drugs Outcomes Research and Policies

Tamás Ágh
Kristina Garuolienė
Anne Gerd Granas
João Gregório
Nilay Aksoy
Nataliia Khanyk
Maja Ortner Hadžiabdić
Przemyslaw Kardas
European Network to Advance Best Practices and Technology on Medication Adherence (ENABLE) Collaborators
Emma Aarnio

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390629

709 views

Original Research

Accepted on 01 Oct 2024

Non-persistence with multiple secondary prevention medications for peripheral arterial disease among older hypertensive patients

in Drugs Outcomes Research and Policies

Martin Wawruch
Miriam Petrova
Denisa Celovska
Sofa Dewi Alfian
Tomas Tesar
Jan Murin
Michal Trnka
Tomas Paduch
Emma Aarnio

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464689

Opinion

Published on 01 Oct 2024

Challenges for esketamine nasal spray in China: use and management

in Drugs Outcomes Research and Policies

Jianhong Wu
Jun Gu
Linghe Qiu
Xin Jin
Zhenhe Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1429435

418 views

Original Research

Published on 01 Oct 2024

Analysis of criteria for choosing drug treatment strategies in allergic rhinitis

in Drugs Outcomes Research and Policies

Damian Grzegorzewski
Marharyta Sobczak
Michał Tołkacz
Rafał Pawliczak

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1340554

456 views

Original Research

Published on 01 Oct 2024

Development of an evaluation system for rational drug use in patients with chronic kidney disease using the Delphi method

in Drugs Outcomes Research and Policies

Wenjie Yao
Xiaolan Ye
Guobing Zhang
Yan Ren
Qilong Gao
Xinfeng Ren
Yao Liu
Ping Huang
Jianlan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1183118

371 views

Original Research

Published on 30 Sep 2024

Clinical drug interactions between voriconazole and 38 other drugs: a retrospective analysis of adverse events

in Drugs Outcomes Research and Policies

Ben-Nian Huo
Ling Shu
Jian-Wen Xiao
Nan-Ge Yin
Mao-Lin Ai
Yun-Tao Jia
Lin Song

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1292163

1,320 views

Policy and Practice Reviews

Published on 30 Sep 2024

A practical assessment protocol for clinically relevant P-glycoprotein-mediated drug-drug interactions

in Drugs Outcomes Research and Policies

Leonie Bogaard
Kayan Tsoi
Bas van de Steeg
Esther F. A. Brandon
Lisanne Geers
Margreet van Herwaarden
Frank Jansman
Dominique Maas
Margje Monster-Simons
David S. Y. Ong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412692

959 views

Original Research

Published on 26 Sep 2024

Enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma: a cost-effectiveness analysis from China based on the EV-302 trial

in Drugs Outcomes Research and Policies

Maojin You
Qiaoyan Zheng
Ying He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412292

804 views

Original Research

Published on 26 Sep 2024

Gaucher disease in Brazil: a comprehensive 16 year retrospective study on survival, cost, and treatment insights

in Drugs Outcomes Research and Policies

Marcus Carvalho Borin
Juliana Alvares-Teodoro
Francisco Assis Acurcio
Augusto Afonso Guerra

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1433970

692 views

Original Research

Published on 25 Sep 2024

The dose of remimazolam combined with sufentanil for the induction of general anesthesia in obese patients undergoing bariatric surgery: an up-and-down sequential allocation trial

in Drugs Outcomes Research and Policies

Minghui Chen
Huiying Wang
Jiajun Sun
Tao Zhang
Xiaoyin Niu
Tingting Zhang
Jian Liu
Xuan Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411856

657 views

Editorial

Published on 25 Sep 2024

Editorial: Internet pharmacies and the online pharmacy market: trends, perspectives and challenges

in Drugs Outcomes Research and Policies

András Fittler
Norah Othman Abanmy
Anna Serefko
Inayat Ur Rehman
Róbert György Vida

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1489396

564 views

Original Research

Published on 24 Sep 2024

Mining and evaluation of adverse event signals for capmatinib based on the FAERS database

in Drugs Outcomes Research and Policies

Xinnan Chen
Ying Jiang
Haohao Zhu
Man Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1417661

781 views
1 citation

Original Research

Published on 23 Sep 2024

Cost-effectiveness analysis of direct oral anticoagulants versus low-molecular-weight heparin and no thromboprophylaxis in primary prevention of cancer-associated venous thromboembolism in China

in Drugs Outcomes Research and Policies

Yue Wu
TianChen Yin
GuiLin Jian
Tao Wan
Benhong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1373333

721 views

Navigation group

Articles

Design and validation of a questionnaire to measure the attitudes of health professionals towards immigrants (AHPI)

Pathways for non-manufacturers to drive generic drug repurposing for cancer in the U.S.

Management of blood lipids in post-kidney transplant patients: a systematic review and network meta-analysis

Identifying and presenting key country-specific indicators related to medication adherence: a comprehensive study across European countries

Non-persistence with multiple secondary prevention medications for peripheral arterial disease among older hypertensive patients

Challenges for esketamine nasal spray in China: use and management

Analysis of criteria for choosing drug treatment strategies in allergic rhinitis

Development of an evaluation system for rational drug use in patients with chronic kidney disease using the Delphi method

Clinical drug interactions between voriconazole and 38 other drugs: a retrospective analysis of adverse events

A practical assessment protocol for clinically relevant P-glycoprotein-mediated drug-drug interactions

Enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma: a cost-effectiveness analysis from China based on the EV-302 trial

Gaucher disease in Brazil: a comprehensive 16 year retrospective study on survival, cost, and treatment insights

The dose of remimazolam combined with sufentanil for the induction of general anesthesia in obese patients undergoing bariatric surgery: an up-and-down sequential allocation trial

Editorial: Internet pharmacies and the online pharmacy market: trends, perspectives and challenges

Mining and evaluation of adverse event signals for capmatinib based on the FAERS database

Cost-effectiveness analysis of direct oral anticoagulants versus low-molecular-weight heparin and no thromboprophylaxis in primary prevention of cancer-associated venous thromboembolism in China